• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1992 Fiscal Year Final Research Report Summary

The Development of the Strategy for the Presumption of the Tertiary Structure of Protein Kinases by Specific Inhibitors

Research Project

Project/Area Number 02557009
Research Category

Grant-in-Aid for Developmental Scientific Research (B)

Allocation TypeSingle-year Grants
Research Field General pharmacology
Research InstitutionNagoya University

Principal Investigator

HIDAKA Hiroyoshi  Nagoya university, Pharmacology, Professor, 医学部, 教授 (80100171)

Co-Investigator(Kenkyū-buntansha) TOKUMITSU Hiroshi  Nagoya University, Pharmacology, Associate Professor, 医学部, 助手 (20237077)
WATANABE Masato  Nagoya University, Pharmacology, Associate Professor, 医学部, 助手 (30220924)
HAGIWARA Masatoshi  Nagoya University, Pharmacology, Associate Professor, 医学部, 助手 (10208423)
KOBAYASHI Ryoji  Nagoya University, Pharmacology, Assistant Professor, 医学部, 助教授 (00020917)
Project Period (FY) 1990 – 1992
KeywordsProtein kinase / Protein Kinase Inhibitor / Inhibitor Data Base
Research Abstract

Protein kinases are enzymes which tansfer Pi into some proteins. These reactions have been revealed to be involved in the regulation of many cellular function. now that the number of protein kinases has reached to over 100, it is essential to study them with structural and functional approach to clarify the physiological function of each protein kinase. The aim of our study is, (1) to presume the tertiary structure of the functional domain of protein kinase, (2) to develop the new specific protein kinase inhibitors, and (3), it is final aim, to clarify the physiological function of protein kinases. Using specific inhibitor for Ca2+/calmodulin dependent protein kinase II(CaM kinase II), KN-62, we succeeded in revealing the involvement of CaM kinase II in smooth muscle contraction, the central regulation of systemic pressure, secretion of insulin or endotherin and so on. H-89, specific inhibitor for cAMP dependent protein kinase(A-kinase), revealed the involvement of the A-kinase in the regulation of transcription of c-fos gene, and in the regulation of induction of immediately early genes. We succeeded in synthesizing the novel specific inhibitor for CaM kinase II or for the novel protein kinase activated by MAP kinase, which is a key molecule for regulating the signals induced by various extracellular stimuli. KN-62 was revealed to inhibit CaM kinase V which was a novel Ca2+/calmodulin dependent protein kinase with respect with calmodulin. On the basis of this result, it will be suggested that the calmodulin binding domain of CaM kinase II is quite similar to that of CaM kinase V.
Taken together, we succeeded in clarifying the function of protein kinases, in developing the new specific inhibitors, and in clearing the similarity between the tertiary structure of calmodulin binding domain of CaM kinase II and CaM kinase V.

  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] H.TOKUMITSU et al.: "NK-62,1-[N,O-bis(isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazin,a specific inhibitor of Ca^<2+>/calmodulin-dependent protein kinaseII." J.Biol.Chem.265. 4315-4320 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] H.HIDAKA et al.: "Molecular Pharmacology of protein kinases." Neurosci.Res.15. 431-434 (1990)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] H.HIDAKA et al.: "Properties and use of H-series compounds as protein kinase inhibitors." Methods in Enzymology. 201. 328-339 (1991)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] H.HIDAKA et al.: "Pharmacology of protein kinase inhibitors." Annu.Rev.Pharmacol.Toxicol.32. 375-395 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] D.Stokoe et al.: "MAPKAP kinase-2;a novel protein kinase activated by nitogen-activated protein kinase." The EMBO Journal. 11. 3985-3994 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] G.Li et al.: "Inhibition of voltage-gated Ca^<2+> channels and insulin secretion in HIT cells by the Ca^<2+>/calmodulin-dependent protein kinase II inhibitor KN-62:Comparison with antagonisits of calmodulin and L-type Ca" Molecular Pharmacology. 42. 489-498 (1992)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] H. Tokumitsu et al.: "KN-62, 1-[N,O-bis(isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazine, a specific inhibitor of Ca^<2+>/calmodulin-dependent protein kinase II." J. Biol. Chem.265. 4315-4320 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H. Hidaka et al.: "Molecular Pharmacology of protein kinases." Neurosci. Res.15. 431-434 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H. Hidaka et al.: "Properties and use of H-series compounds as protein kinase inhibitors" Methods in Enzymology. 201. 328-339 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] H. Hidaka et al.: "Pharmacology of protein kinase inhibitors." Annu. Rev. Pharmacol. Toxicol.32. 375-395 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] D. Stokoe et al.: "MAPKAP kinase-2; a novel protein kinase activated by nitogen-activated kinase." The EMBO Journal. 11. 3985-3994 (1992)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] G. Li et al.: "Inhibition of voltage-gated Ca^<2+> channels and insulin secretion in HIT cells by the Ca^<2+>/calmodulin-dependent protein kinase II inhibitor KN-62: Comparison with antagonisits of calmodulin and L-type Ca^<2+> channels." Molecular Pharmacology. 42. 489-498 (1992)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 1994-03-24  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi